<DOC>
	<DOCNO>NCT00121654</DOCNO>
	<brief_summary>The study aim assess safety efficacy Spinal Cord Stimulation ( SCS ) treatment refractory angina pectoris single blind , prospective , multicenter study . Sixty patient refractory angina new SCS device implantation randomize one three treatment group : - paresthesic SCS ; - subliminal SCS ; - low ( non effective ) stimulation ( control ) . Clinical follow-up do 1 3 month . Control group patient randomize paresthesic SCS subliminal SCS another 3 month 2 group reassess 6 month .</brief_summary>
	<brief_title>Spinal Cord Stimulation ( SCS ) Refractory Angina</brief_title>
	<detailed_description>Aim study ass safety efficacy Spinal Cord Stimulation ( SCS ) treatment refractory angina pectoris single blind , prospective , multicenter study . The study also assess whether subliminal SCS may effective paresthesic SCS patient . Sixty consecutive patient refractory angina new SCS device implantation randomize one three treatment group : - paresthesic SCS ( group 1 ) ; - subliminal SCS ( 75-80 % paresthesic threshold ; group 2 ) ; - low stimulation , consist hour SCS day 0.05 mV intensity , significant stimulator effect ( sham stimulation , group 3 ) . Study Procedure Medical history , clinical data , drug therapy , Angina Canadian Cardiovascular Society ( CCS ) classification , Seattle Angina Questionnaire ( SAQ ) , quality life estimation EuroQoL scale , detailed evaluation angina attack ( frequency , intensity , duration episode ; nitrate assumption ) accord structure diary , number hospitalization , emergency room ( ER ) admission cardiological visit previous 6 month treadmill exercise stress test result obtain baseline visit . Patients fulfil inclusion criterion undergo SCS implant . During implant , stimulation test perform check paresthesic coverage angina pain chest area . Patients adequate paresthesia randomize one 3 group . Follow-up visit perform 1 , 3 , 6 , 12 month SCS implant . Drug therapy change least first 3 month . Patients assign group 2 ( subliminal SCS ) assign group 3 ( sham SCS ) blind assign treatment . After 3 month group 3 , patient randomize group 1 group 2 reassess 6-month follow-up ( comparison paresthesic versus subliminal SCS ) . The control study end 6-month follow-up , investigator decide best stimulation individual patient . Every patient follow 12 month SCS implant . Clinical assessment do follow-up visit . Exercise stress test result repeat 3- , 6- 12-month follow-up visit .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Stable angina pectoris refractory optimal medical therapy , least 10 angina episode three week previous SCS implant ; Documentation coronary artery disease reversible myocardial ischaemia ; Patient candidate refuse surgical percutaneous coronary revascularization ; Availability followup visit ; Written inform consent . Severe spinal cord diseases prevent catheter position epidural space ; No paresthesic coverage angina pain area SCS ; Unstable angina pectoris ; Female patient fertile age ; Enrolment study ; Need anticoagulant therapy ; Patients need diathermy treatment ; Life expectancy &lt; 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Angina pectoris</keyword>
	<keyword>Spinal cord stimulation</keyword>
	<keyword>Refractory angina pectoris</keyword>
</DOC>